The cost of an Epipen’s main ingredient is ‘less than a Big Mac’, says pharmaceuticals boss who wants to sell one for less than $100 | Daily Mail Online

 

  • Mark Baum is the CEO of San Diego drug maker Imprimis Pharmaceuticals
  • Wants to launch a version of the EpiPen under $100 by the end of the year
  • Current maker Mylan has taken price from below $100 to more than $600
  • Mylan responded to outcry with $300 generic version of life-saving device
  • But Baum says one mg of main ingredient epinephrine costs a few bucks
  • EpiPens contain up to 0.3 mg of epinephrine – less than three times that 

The key ingredient of an EpiPen costs less than a Big Mac, according to a pharmaceuticals boss.

Mark Baum, the CEO of San Diego-based drug maker Imprimis Pharmaceuticals, hopes to launch a discounted version of the life-saving device by the end of the year.

Baum believes it is possible to sell an EpiPen – and profit from the sale – for less than $100.

Current EpiPEn manufacturer Mylan has raised the price from less than $100 to more than $600 since 2007, drawing outrage from parents, politicians and consumer groups.

 

 

Source: The cost of an Epipen’s main ingredient is ‘less than a Big Mac’, says pharmaceuticals boss who wants to sell one for less than $100 | Daily Mail Online